Home/Filings/4/0001610717-25-000007
4//SEC Filing

Reider Paul 4

Accession 0001610717-25-000007

CIK 0001512762other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 8:50 PM ET

Size

7.3 KB

Accession

0001610717-25-000007

Insider Transaction Report

Form 4
Period: 2025-01-03
Reider Paul
Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-01-04$1.66/sh2,277$3,78086,927 total
  • Award

    Stock Option (Right to Buy)

    2025-01-03+160,000160,000 total
    Exercise: $1.66Exp: 2035-01-03Common Stock (160,000 underlying)
Footnotes (2)
  • [F1]Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.
  • [F2]The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Coherus BioSciences, Inc.

CIK 0001512762

Entity typeother

Related Parties

1
  • filerCIK 0001970033

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:50 PM ET
Size
7.3 KB